Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | GPCR, family 2 | 0.0017 | 0.0456 | 0.1727 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.2028 | 0.7677 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.001 | 0.0162 | 0.0615 |
Toxoplasma gondii | hypothetical protein | 0.0006 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.0456 | 0.1727 |
Schistosoma mansoni | smad1 5 8 and | 0.001 | 0.0162 | 0.0615 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0017 | 0.0456 | 0.0299 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.001 | 0.0162 | 0.0615 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.2028 | 0.7677 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.1266 | 0.479 |
Loa Loa (eye worm) | mucolipin 1 | 0.007 | 0.2642 | 0.2521 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.2028 | 0.7677 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.1266 | 0.1121 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.001 | 0.0162 | 0.0615 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0017 | 0.0456 | 0.1727 |
Schistosoma mansoni | mucolipin | 0.0064 | 0.2401 | 0.9087 |
Echinococcus multilocularis | Smad4 | 0.001 | 0.0162 | 0.0615 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.2028 | 0.7677 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0006 | 0 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0054 | 0.1963 | 0.183 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0017 | 0.0456 | 0.0299 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0017 | 0.0456 | 0.1727 |
Schistosoma mansoni | smad1 5 8 and | 0.001 | 0.0162 | 0.0615 |
Toxoplasma gondii | hypothetical protein | 0.0006 | 0 | 0.5 |
Trypanosoma cruzi | Polycystin cation channel, putative | 0.0006 | 0 | 0.5 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0017 | 0.0456 | 0.1727 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0249 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.0456 | 0.1727 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.0456 | 0.1727 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.5682 | 0.5611 |
Echinococcus granulosus | Smad4 | 0.001 | 0.0162 | 0.0615 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0017 | 0.0456 | 0.1727 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0037 | 0.1266 | 0.1121 |
Echinococcus multilocularis | smad | 0.001 | 0.0162 | 0.0615 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0054 | 0.1963 | 0.183 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0054 | 0.1963 | 0.183 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0017 | 0.0456 | 0.0299 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.001 | 0.0162 | 0.0615 |
Schistosoma mansoni | mucolipin | 0.007 | 0.2642 | 1 |
Echinococcus granulosus | smad | 0.001 | 0.0162 | 0.0615 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.0456 | 0.1727 |
Schistosoma mansoni | smad1 5 8 and | 0.001 | 0.0162 | 0.0615 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.2028 | 0.7677 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.1963 | 0.183 |
Schistosoma mansoni | Smad4 | 0.001 | 0.0162 | 0.0615 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0456 | 0.0299 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.2028 | 0.1897 |
Schistosoma mansoni | smad | 0.001 | 0.0162 | 0.0615 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.2028 | 0.7677 |
Echinococcus granulosus | mucolipin 3 | 0.007 | 0.2642 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.2028 | 0.1897 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.2028 | 0.7677 |
Trypanosoma brucei | Polycystin cation channel, putative | 0.0006 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0006 | 0 | 0.5 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.001 | 0.0162 | 0.0615 |
Echinococcus granulosus | GPCR family 2 | 0.0017 | 0.0456 | 0.1727 |
Trypanosoma cruzi | Polycystin cation channel, putative | 0.0006 | 0 | 0.5 |
Echinococcus multilocularis | mucolipin 3 | 0.007 | 0.2642 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.5682 | 0.5611 |
Leishmania major | hypothetical protein, conserved | 0.0006 | 0 | 0.5 |
Brugia malayi | Coelomocyte uptake defective protein 5 | 0.007 | 0.2642 | 0.2521 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.5682 | 0.5611 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.